These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 16423995)

  • 1. PEG10 is a c-MYC target gene in cancer cells.
    Li CM; Margolin AA; Salas M; Memeo L; Mansukhani M; Hibshoosh H; Szabolcs M; Klinakis A; Tycko B
    Cancer Res; 2006 Jan; 66(2):665-72. PubMed ID: 16423995
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alterations in specific gene expression and focal neoplastic growth during spontaneous hepatocarcinogenesis in albumin-SV40 T antigen transgenic rats.
    Dragan YP; Sargent LM; Babcock K; Kinunen N; Pitot HC
    Mol Carcinog; 2004 Jul; 40(3):150-9. PubMed ID: 15224347
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PEG10 directly regulated by E2Fs might have a role in the development of hepatocellular carcinoma.
    Wang C; Xiao Y; Hu Z; Chen Y; Liu N; Hu G
    FEBS Lett; 2008 Aug; 582(18):2793-8. PubMed ID: 18625225
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Androgen activates PEG10 to promote carcinogenesis in hepatic cancer cells.
    Jie X; Lang C; Jian Q; Chaoqun L; Dehua Y; Yi S; Yanping J; Luokun X; Qiuping Z; Hui W; Feili G; Boquan J; Youxin J; Jinquan T
    Oncogene; 2007 Aug; 26(39):5741-51. PubMed ID: 17369855
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mnt-deficient mammary glands exhibit impaired involution and tumors with characteristics of myc overexpression.
    Toyo-oka K; Bowen TJ; Hirotsune S; Li Z; Jain S; Ota S; Escoubet-Lozach L; Garcia-Bassets I; Lozach J; Rosenfeld MG; Glass CK; Eisenman R; Ren B; Hurlin P; Wynshaw-Boris A
    Cancer Res; 2006 Jun; 66(11):5565-73. PubMed ID: 16740691
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combined serum and tissue proteomic study applied to a c-Myc transgenic mouse model of hepatocellular carcinoma identified novel disease regulated proteins suitable for diagnosis and therapeutic intervention strategies.
    Ritorto MS; Borlak J
    J Proteome Res; 2011 Jul; 10(7):3012-30. PubMed ID: 21644509
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phosphorylation regulates Myc expression via prolonged activation of the mitogen-activated protein kinase pathway.
    Wang Z; Ge L; Wang M; Carr BI
    J Cell Physiol; 2006 Jul; 208(1):133-40. PubMed ID: 16596619
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Distribution of oval cells and c-myc mRNA expression in mouse hepatocarcinogenesis.
    Fang CH; Zhang GQ; Zhu XY; Gong JQ
    Hepatobiliary Pancreat Dis Int; 2004 Aug; 3(3):433-9. PubMed ID: 15313684
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The imprinting status of genetic imprinted gene PEG10 in human hepatocellular carcinomas].
    Gao Y; Zhang HD; Lin JS; Zhang MP; Zhang RG
    Zhonghua Gan Zang Bing Za Zhi; 2010 Dec; 18(12):894-9. PubMed ID: 21205473
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Annexin A8 is up-regulated during mouse mammary gland involution and predicts poor survival in breast cancer.
    Stein T; Price KN; Morris JS; Heath VJ; Ferrier RK; Bell AK; Pringle MA; Villadsen R; Petersen OW; Sauter G; Bryson G; Mallon EA; Gusterson BA
    Clin Cancer Res; 2005 Oct; 11(19 Pt 1):6872-9. PubMed ID: 16203777
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The tumor suppressor KLF11 mediates a novel mechanism in transforming growth factor beta-induced growth inhibition that is inactivated in pancreatic cancer.
    Buck A; Buchholz M; Wagner M; Adler G; Gress T; Ellenrieder V
    Mol Cancer Res; 2006 Nov; 4(11):861-72. PubMed ID: 17114344
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metastasis tumor antigen family proteins during breast cancer progression and metastasis in a reliable mouse model for human breast cancer.
    Zhang H; Stephens LC; Kumar R
    Clin Cancer Res; 2006 Mar; 12(5):1479-86. PubMed ID: 16533771
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The c-myc and PyMT oncogenes induce different tumor types in a somatic mouse model for pancreatic cancer.
    Lewis BC; Klimstra DS; Varmus HE
    Genes Dev; 2003 Dec; 17(24):3127-38. PubMed ID: 14681205
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The hepatitis B virus X gene potentiates c-myc-induced liver oncogenesis in transgenic mice.
    Terradillos O; Billet O; Renard CA; Levy R; Molina T; Briand P; Buendia MA
    Oncogene; 1997 Jan; 14(4):395-404. PubMed ID: 9053836
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Developmental stage determines the effects of MYC in the mammary epithelium.
    Blakely CM; Sintasath L; D'Cruz CM; Hahn KT; Dugan KD; Belka GK; Chodosh LA
    Development; 2005 Mar; 132(5):1147-60. PubMed ID: 15689376
    [TBL] [Abstract][Full Text] [Related]  

  • 16. p130Cas as a new regulator of mammary epithelial cell proliferation, survival, and HER2-neu oncogene-dependent breast tumorigenesis.
    Cabodi S; Tinnirello A; Di Stefano P; BisarĂ² B; Ambrosino E; Castellano I; Sapino A; Arisio R; Cavallo F; Forni G; Glukhova M; Silengo L; Altruda F; Turco E; Tarone G; Defilippi P
    Cancer Res; 2006 May; 66(9):4672-80. PubMed ID: 16651418
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Unopposed c-MYC expression in benign prostatic epithelium causes a cancer phenotype.
    Williams K; Fernandez S; Stien X; Ishii K; Love HD; Lau YF; Roberts RL; Hayward SW
    Prostate; 2005 Jun; 63(4):369-84. PubMed ID: 15937962
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fgf10 is an oncogene activated by MMTV insertional mutagenesis in mouse mammary tumors and overexpressed in a subset of human breast carcinomas.
    Theodorou V; Boer M; Weigelt B; Jonkers J; van der Valk M; Hilkens J
    Oncogene; 2004 Aug; 23(36):6047-55. PubMed ID: 15208658
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential alteration of stem and other cell populations in ducts and lobules of TGFalpha and c-Myc transgenic mouse mammary epithelium.
    Chepko G; Slack R; Carbott D; Khan S; Steadman L; Dickson RB
    Tissue Cell; 2005 Oct; 37(5):393-412. PubMed ID: 16137731
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-throughput tissue microarray analysis of c-myc activation in chronic liver diseases and hepatocellular carcinoma.
    Chan KL; Guan XY; Ng IO
    Hum Pathol; 2004 Nov; 35(11):1324-31. PubMed ID: 15668888
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.